{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:52:08Z","timestamp":1791193928156,"version":"4.1.0"},"reference-count":100,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2014,1,1]]},"published-print":{"date-parts":[[2014,10]]},"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) affects up to a third of the population in many developed countries. Between 10% and 30% of patients with NAFLD have non-alcoholic steatohepatitis (NASH) that can progress to cirrhosis. There are metabolic risk factors common to both NAFLD and cardiovascular disease, so patients with NASH have an increased risk of liver-related and cardiovascular death. Management of patients with NAFLD depends largely on the stage of disease, emphasising the importance of careful risk stratification. There are four main areas to focus on when thinking about management strategies in NAFLD: lifestyle modification, targeting the components of the metabolic syndrome, liver-directed pharmacotherapy for high risk patients and managing the complications of cirrhosis.<\/jats:p>","DOI":"10.1136\/flgastro-2013-100404","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T23:23:19Z","timestamp":1390432999000},"page":"277-286","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":84,"title":["Non-alcoholic fatty liver disease: a practical approach to treatment"],"prefix":"10.1136","volume":"5","author":[{"given":"J K","family":"Dyson","sequence":"first","affiliation":[{"name":"Liver Unit, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q M","family":"Anstee","sequence":"additional","affiliation":[{"name":"Liver Unit, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"name":"Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"McPherson","sequence":"additional","affiliation":[{"name":"Liver Unit, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"},{"name":"Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,1,22]]},"reference":[{"key":"2025090709024256000_5.4.277.1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20734"},{"key":"2025090709024256000_5.4.277.2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20466"},{"key":"2025090709024256000_5.4.277.3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300342"},{"key":"2025090709024256000_5.4.277.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70506-8"},{"key":"2025090709024256000_5.4.277.5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840120505"},{"key":"2025090709024256000_5.4.277.6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.09.038"},{"key":"2025090709024256000_5.4.277.7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21327"},{"key":"2025090709024256000_5.4.277.8","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.41"},{"key":"2025090709024256000_5.4.277.9","doi-asserted-by":"crossref","unstructured":"Dyson JK Anstee QM Mcpherson S . Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol 2014;5:211\u20138.","DOI":"10.1136\/flgastro-2013-100403"},{"key":"2025090709024256000_5.4.277.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d3897"},{"key":"2025090709024256000_5.4.277.11","unstructured":"NICE. NICE Clinical guidelines. CG43 Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children. In: Care NIfHaCEaNCCfP, ed., 2006."},{"key":"2025090709024256000_5.4.277.12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23276"},{"key":"2025090709024256000_5.4.277.13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22575"},{"key":"2025090709024256000_5.4.277.14","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2032"},{"key":"2025090709024256000_5.4.277.15","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00210.2009"},{"key":"2025090709024256000_5.4.277.16","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0b013e3181df16d9"},{"key":"2025090709024256000_5.4.277.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.06.010"},{"key":"2025090709024256000_5.4.277.18","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2011.242073"},{"key":"2025090709024256000_5.4.277.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.08.012"},{"key":"2025090709024256000_5.4.277.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035622"},{"key":"2025090709024256000_5.4.277.21","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.06.047"},{"key":"2025090709024256000_5.4.277.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907929"},{"key":"2025090709024256000_5.4.277.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04912.x"},{"key":"2025090709024256000_5.4.277.24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.520"},{"key":"2025090709024256000_5.4.277.25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/ajcn\/86.2.285","article-title":"Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease","volume":"86","author":"Zivkovic","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"2025090709024256000_5.4.277.26","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.2008.26720"},{"key":"2025090709024256000_5.4.277.27","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00145.2011"},{"key":"2025090709024256000_5.4.277.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.02.012"},{"key":"2025090709024256000_5.4.277.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.08.018"},{"key":"2025090709024256000_5.4.277.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.04.013"},{"key":"2025090709024256000_5.4.277.31","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.04.052"},{"key":"2025090709024256000_5.4.277.32","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22525"},{"key":"2025090709024256000_5.4.277.33","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.7.661"},{"key":"2025090709024256000_5.4.277.34","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00921.2011"},{"key":"2025090709024256000_5.4.277.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.02.004"},{"key":"2025090709024256000_5.4.277.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066254"},{"key":"2025090709024256000_5.4.277.37","doi-asserted-by":"crossref","unstructured":"Chavez-Tapia NC Tellez-Avila FI Barrientos-Gutierrez T . Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database System Rev 2010:CD007340.","DOI":"10.1002\/14651858.CD007340.pub2"},{"key":"2025090709024256000_5.4.277.38","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21472"},{"key":"2025090709024256000_5.4.277.39","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.cgh.2011.07.007","article-title":"Increased perioperative mortality following bariatric surgery among patients with cirrhosis","volume":"9","author":"Mosko","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090709024256000_5.4.277.40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.soard.2012.07.021","article-title":"Bariatric surgery in patients with liver cirrhosis","volume":"9","author":"Shimizu","year":"2013","journal-title":"Surg Obes Relat Dis"},{"key":"2025090709024256000_5.4.277.41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060326"},{"key":"2025090709024256000_5.4.277.42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61514-1"},{"key":"2025090709024256000_5.4.277.43","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-2412"},{"key":"2025090709024256000_5.4.277.44","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-010-0027-y"},{"key":"2025090709024256000_5.4.277.45","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.10.1180"},{"key":"2025090709024256000_5.4.277.46","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.04.001"},{"key":"2025090709024256000_5.4.277.47","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-1-200501040-00110"},{"key":"2025090709024256000_5.4.277.48","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c5702"},{"key":"2025090709024256000_5.4.277.49","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.864"},{"key":"2025090709024256000_5.4.277.50","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.216077"},{"key":"2025090709024256000_5.4.277.51","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32835d72cf"},{"key":"2025090709024256000_5.4.277.52","unstructured":"NICE. NICE clinical guidelines. CG87 Type 2 diabetes: The management of type 2 diabetes. In: NICE, ed., 2010."},{"key":"2025090709024256000_5.4.277.53","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.405"},{"key":"2025090709024256000_5.4.277.54","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"2025090709024256000_5.4.277.55","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2504"},{"key":"2025090709024256000_5.4.277.56","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12149"},{"key":"2025090709024256000_5.4.277.57","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF03345423","article-title":"Does use of metformin protect against cancer in Type 2 diabetes mellitus?","volume":"35","author":"Bo","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"2025090709024256000_5.4.277.58","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301708"},{"key":"2025090709024256000_5.4.277.59","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50161"},{"key":"2025090709024256000_5.4.277.60","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.25540"},{"key":"2025090709024256000_5.4.277.61","unstructured":"NICE. NICE clinical guidelines. CG127 Hypertension: Clinical management of primary hypertension in adults. In: NICE, ed., 2011."},{"key":"2025090709024256000_5.4.277.62","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00695-4"},{"key":"2025090709024256000_5.4.277.63","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4254\/wjh.v4.i12.327","article-title":"Nonalcoholic fatty liver disease and the renin-angiotensin system: implications for treatment","volume":"4","author":"Paschos","year":"2012","journal-title":"World J Hepatol"},{"key":"2025090709024256000_5.4.277.64","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.942"},{"key":"2025090709024256000_5.4.277.65","first-page":"448","article-title":"Do angiotensin converting enzyme inhibitors or angiotensin receptor blockers prevent diabetes mellitus? A meta-analysis","volume":"17","author":"Al-Mallah","year":"2010","journal-title":"Cardiology J"},{"key":"2025090709024256000_5.4.277.66","unstructured":"NICE. NICE clinical guidelines. CG67 Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. In: NICE, ed., 2010."},{"key":"2025090709024256000_5.4.277.67","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67394-1"},{"key":"2025090709024256000_5.4.277.68","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61272-X"},{"key":"2025090709024256000_5.4.277.69","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.10.005"},{"key":"2025090709024256000_5.4.277.70","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/obr.12020","article-title":"Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis","volume":"14","author":"Musso","year":"2013","journal-title":"Obes Rev"},{"key":"2025090709024256000_5.4.277.71","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31816d83e4"},{"key":"2025090709024256000_5.4.277.72","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23527"},{"key":"2025090709024256000_5.4.277.73","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24199"},{"key":"2025090709024256000_5.4.277.74","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer","year":"2012","journal-title":"J Hepatol"},{"key":"2025090709024256000_5.4.277.75","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00349-0"},{"key":"2025090709024256000_5.4.277.76","doi-asserted-by":"crossref","first-page":"99","DOI":"10.7863\/jum.2001.20.2.99","article-title":"Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients","volume":"20","author":"Kim","year":"2001","journal-title":"J Ultrasound Med"},{"key":"2025090709024256000_5.4.277.77","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-009-0112-0"},{"key":"2025090709024256000_5.4.277.78","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021423"},{"key":"2025090709024256000_5.4.277.79","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn415"},{"key":"2025090709024256000_5.4.277.80","doi-asserted-by":"crossref","first-page":"s836","DOI":"10.1093\/ajcn\/86.3.836S","article-title":"Metabolic syndrome, hyperinsulinemia, and colon cancer: a review","volume":"86","author":"Giovannucci","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"2025090709024256000_5.4.277.81","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-69297-3_5"},{"key":"2025090709024256000_5.4.277.82","doi-asserted-by":"publisher","DOI":"10.1007\/s10059-013-0169-8"},{"key":"2025090709024256000_5.4.277.83","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200113505"},{"key":"2025090709024256000_5.4.277.84","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.3748\/wjg.15.2506","article-title":"Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease","volume":"5","author":"Donadon","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2025090709024256000_5.4.277.85","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24982"},{"key":"2025090709024256000_5.4.277.86","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.01.053"},{"key":"2025090709024256000_5.4.277.87","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.475"},{"key":"2025090709024256000_5.4.277.88","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1751"},{"key":"2025090709024256000_5.4.277.89","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0866"},{"key":"2025090709024256000_5.4.277.90","doi-asserted-by":"publisher","DOI":"10.1038\/nature03043"},{"key":"2025090709024256000_5.4.277.91","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-3367"},{"key":"2025090709024256000_5.4.277.92","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.21.2564"},{"key":"2025090709024256000_5.4.277.93","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21907"},{"issue":"(Suppl 3\u20134)","key":"2025090709024256000_5.4.277.94","first-page":"III1","article-title":"UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology","volume":"46","author":"Jalan","year":"2000","journal-title":"Gut"},{"key":"2025090709024256000_5.4.277.95","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.suppl_1.i1"},{"key":"2025090709024256000_5.4.277.96","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.06.061"},{"key":"2025090709024256000_5.4.277.97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.04.008"},{"key":"2025090709024256000_5.4.277.98","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21943"},{"key":"2025090709024256000_5.4.277.99","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/lt.22004","article-title":"Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease","volume":"16","author":"Yalamanchili","year":"2010","journal-title":"Liver Transpl"},{"key":"2025090709024256000_5.4.277.100","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300886"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2013-100404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:02:53Z","timestamp":1757260973000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2013-100404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,22]]},"references-count":100,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,9,3]]},"published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.1136\/flgastro-2013-100404"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2013-100404","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"value":"2041-4137","type":"print"},{"value":"2041-4145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,22]]}}}